Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2010-03-29
2011-12-13
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S278000
Reexamination Certificate
active
08076482
ABSTRACT:
There are provided compounds of the formulaor a pharmaceutically acceptable salt or ester thereof wherein X, Y, W, W′, V, V′, V″, R1, R2and R3are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
REFERENCES:
patent: 7495007 (2009-02-01), Chen et al.
patent: 7553833 (2009-06-01), Liu et al.
patent: 7638548 (2009-12-01), Liu et al.
patent: 7776875 (2010-08-01), Chen et al.
patent: 2007/0213341 (2007-09-01), Chen et al.
patent: 2008/0009486 (2008-01-01), Chen et al.
patent: 2008/0114013 (2008-05-01), Liu et al.
patent: 0288847 (1988-04-01), None
patent: 0 947 511 (1999-10-01), None
patent: 01/05790 (2001-01-01), None
patent: 2006091646 (2006-08-01), None
patent: 2007104664 (2007-09-01), None
patent: 2007104714 (2007-09-01), None
patent: 2008080822 (2008-07-01), None
patent: 2008005268 (2008-10-01), None
patent: 2009080488 (2009-07-01), None
Hans-Dieter Arndt, Dr. Kleine Molekule pp. 4664-4673—XP-002465843.
J. Amer. Chem. Soc. (2005) 127 p. 10130.
Howard C. Ansel, Pharmaceutical Dosage Forms and Drug Delivery Systems, 6th Ed. 1995, pp. 196, 456-457.
Ghosez, L., etal Tetrahedron 1995—11021-11042.
Lippa, B. et al Bioorganic & Med. Chem. Letters, 18 (11), 2008—3359-3363.
Ding et al, J. Med. Chem. (2006) 49:3432-3435.
Sairam, P., Elsevier 303-306.
Simplicio,A., Molecular Diversity Preservation International, 519-547—XP-002503564.
Chen Li
Han Xingchun
Yang Song
Zhang Zhuming
Desai Rita
Hoffmann-La Roche Inc.
Johnston George W.
Roca-Tramaloni Patricia S.
LandOfFree
3,3′-spiroindolinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,3′-spiroindolinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3′-spiroindolinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310037